Literature DB >> 24279195

Diagnosis and evaluation of a patient with rapidly progressive dementia.

Robert C Bucelli1, Beau M Ances.   

Abstract

While the most common dementia is Alzheimer disease (AD), a detailed history is needed to rule out rapidly progressive dementias (RPDs). RPDs are less than two years in duration and have a rate of progression faster typical neurodegenerative diseases. Identification of RPDs is important as some are treatable. This review focuses on the spectrum of RPDs, with special emphasis on paraneoplastic disorders and Creutzfeldt-Jakob disease (CJD).

Entities:  

Mesh：

Year:  2013        PMID： 24279195      PMCID： PMC4217278     

Source DB:  PubMed          Journal:  Mo Med        ISSN： 0026-6620


  19 in total

1.  Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion.

Authors:  Ryuichiro Atarashi; Katsuya Satoh; Kazunori Sano; Takayuki Fuse; Naohiro Yamaguchi; Daisuke Ishibashi; Takehiro Matsubara; Takehiro Nakagaki; Hitoki Yamanaka; Susumu Shirabe; Masahito Yamada; Hidehiro Mizusawa; Tetsuyuki Kitamoto; Genevieve Klug; Amelia McGlade; Steven J Collins; Noriyuki Nishida
Journal:  Nat Med       Date:  2011-01-30       Impact factor: 53.440

Review 2.  The evaluation of rapidly progressive dementia.

Authors:  Michael Henry Rosenbloom; Alireza Atri
Journal:  Neurologist       Date:  2011-03       Impact factor: 1.398

Review 3.  Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis.

Authors:  Myrna R Rosenfeld; Josep O Dalmau
Journal:  Continuum (Minneap Minn)       Date:  2012-04

4.  Rapidly progressive dementia: prion diseases and other rapid dementias.

Authors:  Michael D Geschwind
Journal:  Continuum (Minneap Minn)       Date:  2010-04

Review 5.  Prion propagation, toxicity and degradation.

Authors:  Adriano Aguzzi; Jeppe Falsig
Journal:  Nat Neurosci       Date:  2012-06-26       Impact factor: 24.884

6.  Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants.

Authors:  I Zerr; W J Schulz-Schaeffer; A Giese; M Bodemer; A Schröter; K Henkel; H J Tschampa; O Windl; A Pfahlberg; B J Steinhoff; O Gefeller; H A Kretzschmar; S Poser
Journal:  Ann Neurol       Date:  2000-09       Impact factor: 10.422

7.  Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study.

Authors:  M Otto; L Cepek; P Ratzka; S Doehlinger; I Boekhoff; J Wiltfang; E Irle; G Pergande; B Ellers-Lenz; O Windl; H A Kretzschmar; S Poser; H Prange
Journal:  Neurology       Date:  2004-03-09       Impact factor: 9.910

8.  Role of magnetic resonance imaging, cerebrospinal fluid, and electroencephalogram in diagnosis of sporadic Creutzfeldt-Jakob disease.

Authors:  Leo H Wang; Robert C Bucelli; Erica Patrick; Dhanashree Rajderkar; Enrique Alvarez Iii; Miranda M Lim; Gabriela Debruin; Victoria Sharma; Sonika Dahiya; Robert E Schmidt; Tammie S Benzinger; Beth A Ward; Beau M Ances
Journal:  J Neurol       Date:  2012-09-12       Impact factor: 4.849

9.  Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial.

Authors:  John Collinge; Michele Gorham; Fleur Hudson; Angus Kennedy; Geraldine Keogh; Suvankar Pal; Martin Rossor; Peter Rudge; Durre Siddique; Moira Spyer; Dafydd Thomas; Sarah Walker; Tom Webb; Steve Wroe; Janet Darbyshire
Journal:  Lancet Neurol       Date:  2009-03-09       Impact factor: 44.182

Review 10.  Prion-like spread of protein aggregates in neurodegeneration.

Authors:  Magdalini Polymenidou; Don W Cleveland
Journal:  J Exp Med       Date:  2012-05-07       Impact factor: 14.307
View more
  6 in total

1.  Brain biopsies requiring Creutzfeldt-Jakob disease precautions in the Republic of Ireland 2005-2016.

Authors:  F M Brett; S Looby; A Chalissery; D Chen; C Heaney; J Heffernan; F Cunningham; R Howley; T Loftus; H Kearney; M A Farrell
Journal:  Ir J Med Sci       Date:  2017-08-12       Impact factor: 1.568

Review 2.  Intravascular large B-cell lymphoma presenting clinically as rapidly progressive dementia.

Authors:  F M Brett; D Chen; T Loftus; Y Langan; S Looby; S Hutchinson
Journal:  Ir J Med Sci       Date:  2017-07-19       Impact factor: 1.568

3.  Feasibility Study: Comparison of Frontal Cortex Needle Core Versus Open Biopsy for Detection of Characteristic Proteinopathies of Neurodegenerative Diseases.

Authors:  Geidy E Serrano; Anthony Intorcia; Jeremiah Carew; Glenn Chiarolanza; Jose A Hidalgo; Lucia I Sue; Brittany N Dugger; Megan Saxon-LaBelle; Jessica Filon; Alex Scroggins; Joel Pullen; Brandon E Fornwalt; Sarah Scott; Marwan N Sabbagh; Charles H Adler; Haruhiko Akiyama; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2015-09       Impact factor: 3.685

4.  EBV driven natural killer cell disease of the central nervous system presenting as subacute cognitive decline.

Authors:  Francesca M Brett; Richard Flavin; Daphne Chen; Teresa Loftus; Seamus Looby; Allan McCarthy; Cillian de Gascun; Elaine S Jaffe; Nurul Nor; Mohsen Javadpour; Dominick McCabe
Journal:  Hum Pathol (N Y)       Date:  2017-11

5.  Creutzfeldt-Jakob Disease: Analysis of Four Cases.

Authors:  Ali Al Balushi; Marshall W Meeks; Ghazala Hayat; Jafar Kafaie
Journal:  Front Neurol       Date:  2016-08-29       Impact factor: 4.003

6.  Spectrum of noncerebrovascular rapidly progressive cognitive deterioration: a 2-year retrospective study.

Authors:  Yun Zhang; Ting Gao; Qing-Qing Tao
Journal:  Clin Interv Aging       Date:  2017-10-09       Impact factor: 4.458
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.